Loading…
Sectoral / Thematic · quant Mutual Fund · AMFI code 148560quant ESG Integration Strategy Fund
Disclosed for 71 months, Nov 2020 to Sep 2026.
Portfolio value
₹260 Cr
down ₹28.1 Cr vs Jan 2025
- Stocks held
- 20
- up 4 vs Jan 2025
- Top 10 weight
quant ESG Integration Strategy Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In February 2025 it disclosed 20 stocks worth ₹260 Cr, down ₹28.1 Cr from Jan 2025. Its largest positions were Reliance Industries Limited (9.6%), Life Insurance Corporation Of India (7.1%), Aditya Birla Fashion and Retail Limited (7.0%); the ten largest together made up 65.2% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 22.9% of its equity. Cash and debt stood at 0.7%. Compared with Jan 2025 the fund entered 8 new stocks and exited 4.
Against 229 other Sectoral / Thematic funds
Concentration
90%
Top-10 weight is higher than 90% of peers
Breadth
5%
Holds more stocks than 5% of peers
Cash
10%
Holds more cash than 10% of peers
What these mean: concentration · cash
Holdings in February 2025
Download CSVEvery line the fund disclosed, with the change against Jan 2025. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Reliance Industries Limited | 9.56% | down 0.57 pts | ₹24.9 Cr | down ₹4.3 Cr | Trimmed |
| Life Insurance Corporation Of India | 7.11% | down 0.22 pts | ₹18.5 Cr | down ₹2.6 Cr | Trimmed |
| Aditya Birla Fashion and Retail Limited | 6.97% | down 0.14 pts | ₹18.1 Cr | down ₹2.4 Cr | Trimmed |
| Zydus Wellness Limited | 6.96% | down 0.43 pts | ₹18.1 Cr | down ₹3.2 Cr | Trimmed |
| Pfizer Limited | 6.93% | down 0.08 pts | ₹18 Cr | down ₹2.2 Cr | Trimmed |
| Jio Financial Services Limited | 6.56% | down 0.33 pts | ₹17.1 Cr | down ₹2.8 Cr | Trimmed |
| IndusInd Bank Limited | 6.31% | up 6.31 pts | ₹16.4 Cr | up ₹16.4 Cr | New |
| Bajaj Finserv Ltd. 27/03/2025 Derivative | 6.19% | up 6.19 pts | ₹16.1 Cr | up ₹16.1 Cr | New |
| Aurobindo Pharma Limited | 4.54% | up <0.01 pts | ₹11.8 Cr | down ₹1.3 Cr | Trimmed |
| Divi's Laboratories Limited | 4.13% | up 0.34 pts | ₹10.7 Cr | down ₹19 L | Trimmed |
| Avenue Supermarts Limited 27/03/2025 Derivative | 3.69% | up 3.69 pts | ₹9.6 Cr | up ₹9.6 Cr | New |
| Housing & Urban Development Corporation Limited | 3.47% | up 3.47 pts | ₹9 Cr | up ₹9 Cr | New |
| Bandhan Bank Limited | 3.32% | up 3.32 pts | ₹8.6 Cr | up ₹8.6 Cr | New |
| HFCL Limited | 3.22% | down 0.38 pts | ₹8.4 Cr | down ₹2 Cr | Trimmed |
| Zydus Lifesciences Limited | 2.96% | up 2.96 pts | ₹7.7 Cr | up ₹7.7 Cr | New |
| NTPC Limited | 2.94% | up 2.94 pts | ₹7.6 Cr | up ₹7.6 Cr | New |
| Adani Energy Solutions Limited | 2.80% | down 0.11 pts | ₹7.3 Cr | down ₹1.1 Cr | Trimmed |
| Dr. Reddy's Laboratories Limited 27/03/2025 Derivative | 2.66% | up 2.66 pts | ₹6.9 Cr | up ₹6.9 Cr | New |
| Bajaj Finserv Limited | 2.61% | up 2.61 pts | ₹6.8 Cr | up ₹6.8 Cr | New |
| HDFC Life Insurance Company Limited | 2.17% | down 6.86 pts | ₹5.7 Cr | down ₹20.4 Cr | Trimmed |
| Avenue Supermarts Limited | 1.83% | up 1.83 pts | ₹4.8 Cr | up ₹4.8 Cr | New |
| Dr. Reddy's Laboratories Limited | 1.33% | up 0.02 pts | ₹3.5 Cr | down ₹31 L | Trimmed |
| REC Limited | 1.00% | up 1.00 pts | ₹2.6 Cr | up ₹2.6 Cr | New |
| Cash, TREPS & receivables | 0.73% | up 0.22 pts | ₹1.9 Cr | up ₹42 L | Added |
What changed, Jan 2025 to Feb 2025
New New positions (8)
- IndusInd Bank Limited6.3% · ₹16.4 Cr
- Housing & Urban Development Corporation Limited3.5% · ₹9 Cr
- Bandhan Bank Limited3.3% · ₹8.6 Cr
- Zydus Lifesciences Limited3.0% · ₹7.7 Cr
- NTPC Limited2.9% · ₹7.6 Cr
- Bajaj Finserv Limited2.6% · ₹6.8 Cr
- Avenue Supermarts Limited1.8% · ₹4.8 Cr
- REC Limited1.0% · ₹2.6 Cr
Exited Exited (4)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jan 2025, the weight rose most in Banks (+11.1 pts) and Finance (+6.3 pts), and fell most in Food Products (−14.7 pts) and Insurance (−7.1 pts).
- Banks0.0% → 11.1%new+11.1 pts
- Finance9.4% → 15.7%+6.3 pts
- Pharmaceuticals & Biotechnology18.1% → 22.9%+4.8 pts
- Power3.2% → 6.6%+3.5 pts
- Retailing7.7% → 10.1%+2.4 pts
- Food Products22.8% → 8.0%−14.7 pts
- Insurance17.8% → 10.7%−7.1 pts
- Agricultural Food & Other Products6.1% → 0.0%exited−6.1 pts
- Telecom - Services3.9% → 3.7%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Feb 2022 | Feb 2024 | Aug 2024 | Nov 2024 | Jan 2025 | Feb 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 3.2% | 8.0% | 39.6% | 9.0% | 18.1% | 22.9% |
| Finance | 4.0% | 12.5% | — | 12.3% | 9.4% | 15.7% |
| Banks | 9.7% | 11.6% | — | — | — | 11.1% |
| Petroleum Products | — | 18.6% | — | 9.9% | 11.0% | 11.0% |
| Insurance | 0.6% | 8.6% | 19.4% | 17.6% | 17.8% | 10.7% |
| Retailing | 5.7% | — | 9.1% | 8.0% | 7.7% | 10.1% |
| Food Products | — | 13.0% | 19.7% | 20.9% | 22.8% | 8.0% |
| Power | — | — | — | — | 3.2% | 6.6% |
| Telecom - Services | 14.3% | — | 6.2% | 4.7% | 3.9% | 3.7% |
Allocation in Feb 2025change vs Jan 2025
- Pharmaceuticals & Biotechnology (5)22.9%▲ 4.8 pts
- Finance (4)15.7%▲ 6.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Feb 2025
0.7%
▲ 0.2 pts vs Jan 2025
- Cash alone
- 0.7%
- cash and net receivables
- A year earlier
- 11.4%
- Feb 2024 · now ▼ 10.7 pts
- Last 12 months
- 0.5% – 15.0%
- lowest to highest · record 17.8% in Aug 2023
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.